Chicago Partners Investment Group LLC Chemo Centryx, Inc. Transaction History

Chicago Partners Investment Group LLC

  • $2.81 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$13.18 - $19.83 $321,723 - $484,050
-24,410 Closed
0 $0
Q2 2021

Aug 02, 2021
BUY
$9.59 - $50.88 $150,236 - $797,086
15,666 Added 179.16%
24,410 $355,000
Q1 2021

Apr 28, 2021
BUY
$49.53 - $68.4 $120,357 - $166,212
2,430 Added 38.49%
8,744 $414,000
Q4 2020

Jan 27, 2021
BUY
$47.25 - $65.16 $298,336 - $411,420
6,314 New
6,314 $407,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Chicago Partners Investment Group LLC Portfolio

Follow Chicago Partners Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Partners Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Partners Investment Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email